Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease. / Zucker, B; Ludin, DE; Gerds, TA; Lucking, CH; Landwehrmeyer, BG; Feuerstein, TJ.

In: Naunyn Schmiedebergs Arch Pharmacol, Vol. 370, No. 2, 2004, p. 131.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Zucker, B, Ludin, DE, Gerds, TA, Lucking, CH, Landwehrmeyer, BG & Feuerstein, TJ 2004, 'Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.', Naunyn Schmiedebergs Arch Pharmacol, vol. 370, no. 2, pp. 131.

APA

Zucker, B., Ludin, DE., Gerds, TA., Lucking, CH., Landwehrmeyer, BG., & Feuerstein, TJ. (2004). Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease. Naunyn Schmiedebergs Arch Pharmacol, 370(2), 131.

Vancouver

Zucker B, Ludin DE, Gerds TA, Lucking CH, Landwehrmeyer BG, Feuerstein TJ. Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease. Naunyn Schmiedebergs Arch Pharmacol. 2004;370(2):131.

Author

Zucker, B ; Ludin, DE ; Gerds, TA ; Lucking, CH ; Landwehrmeyer, BG ; Feuerstein, TJ. / Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease. In: Naunyn Schmiedebergs Arch Pharmacol. 2004 ; Vol. 370, No. 2. pp. 131.

Bibtex

@article{7b2e71c5285947b68d6b5fdb77f9fb0c,
title = "Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.",
author = "B Zucker and DE Ludin and TA Gerds and CH Lucking and BG Landwehrmeyer and TJ Feuerstein",
year = "2004",
language = "Udefineret/Ukendt",
volume = "370",
pages = "131",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.

AU - Zucker, B

AU - Ludin, DE

AU - Gerds, TA

AU - Lucking, CH

AU - Landwehrmeyer, BG

AU - Feuerstein, TJ

PY - 2004

Y1 - 2004

M3 - Tidsskriftartikel

VL - 370

SP - 131

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 2

ER -

ID: 178696473